News List

Datar Cancer Genetics, Thyrocare Gulf collaborate to offer oncology based genomic solutions


Datar Cancer Genetics has entered into a collaboration with Bahrain’s Thyrocare Gulf to offer their oncology based genomic solutions in the region.

By Team ABLE

Datar Cancer Genetics Limited has entered into a collaboration with Bahrain-based Thyrocare Gulf to offer their oncology based genomic solutions in the region.

“Our relationship with Thyrocare Gulf expands our footprint into the Middle East to deliver best-in-class genomic solutions,\" commented Rajan Datar, Chairman, Datar Cancer Genetics Limited. \"This collaboration will help change the way healthcare is practiced and allow clinicians to interpret patient’s genomic information to enable better health outcomes and facilitate integration of molecular and genetic analysis as standard of cancer care across the region.”

We are happy that world-class cancer genetics diagnostic solutions are now Made in India,” said Dr. A Velumani Chairman of Thyrocare Gulf Laboratories.

Datar Cancer Genetics has said in the release that the company owns state-of-the-art, College of American Pathologists (CAP), NABL and ISO accredited molecular genomic facility at Nashik, India, with a specialized team of scientists and clinicians who are devoted to developing the world’s best technologies for cancer management using molecular and genetic analysis.